Article citationsMore>>

C. Gridelli, F. Ciardiello, R. Feld, et al., “International Multicenter Randomized Phase III Study of First-Line Erlotinib (E) Followed by Second-Line Cisplatin Plus Gemcitabine (CG) versus First-Line CG followed by Second-Line E in Advanced Non-Small Cell Lung Cancer (aNSCLC): The TORCH Trial,” Journal of Clinical Oncology, Vol. 28, No. 15s, 2010, Abstract 7508.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top